Mary K. Engle

Associate Director

Division:

Division of Advertising Practices

Speeches, Articles, and Statements

• Solar D. Skincare, LLC (Solar D sunscreen) (February 2017)
• Zeltiq Aesthetic, Inc. (CoolSculpting® Cryolipolysis® Body Contouring System) (October 2016)
• Shredlage, LLC and CLAAS of America (corn kernel processors) (September 2016)
• MB Premium Health Labs (Verified Forskolin) – Response to NAD referral (September 2016)
• New Nordic USA, Inc. (Skin Care™ Collagen Filler) – Response to NAD referral (May 2016)
• Nature Works Best Cancer Clinic – Response to NAD referral (March 2016)
• Reynolds Consumer Products (Hefty Slider Bags) – Response to NAD referral (February 2016)
• Steuart Laboratories (Steuart’s Pain Formula) – Response to NAD referral (February 2016)
• SAS Group, Inc. (Dutch Glow™ Amish Wood Milk Furniture Cleaner and Polish) – Response to NAD referral (February 2016)
• American Dream Nutrition, LLC (PhytoZon dietary supplement) – Response to NAD referral (February 2016)
• New Nordic USA, Inc. (Hair Volume dietary supplements) – Response to NAD referral (January 2016)
• Takari International, Inc. (Danisa Traditional Butter Cookies) – Response to NAD referral (December 2015)
• Health Energetic Labs (HeightGrowth Plus) – Response to NAD referral (December 2015)
• Pursuit of Research (Nutriiveda) – Response to NAD referral (November 2015)
• RDK Global (Provailen) – Response to NAD referral (November 2015)
• Aspire Beverages Co., LLC (Sports Drink) – Response to NAD referral (October 2015)
• Wal-Mart Stores, Inc. (“Raise in Pay” Commercial) – Response to NAD referral (September 2015)
• Plymouth Direct, Inc. (BeActive Brace) – Response to ERSP referral (July 2015)
• Terro Novo, Inc. (EarthGuard Fiber Matrix Industrial-Use Soil Erosion Control Products) – Response to NAD referral (June 2015)
• Body Armor Nutrition LLC (BODYARMOR SuperDrink) – Response to NAD referral (May 2015)
• Cortec Corpation (Vapor Corrosion Inhibiting Film) – Response to NAD referral (January 2015)
• Talking Rain Beverage Company (Sparkling ICE) – Response to NAD referral (January 2015)
• MiMedx Group, Inc. (EpiFix and EpiFix Micronized wound care products) – Response to NAD referral (June 2014)
• Prepared Statement of the Federal Trade Commission On Protecting Consumers From False and Deceptive Advertising of Weight-Loss Products – Before the Subcommittee on Consumer Protection, Product Safety, and Insurance of the Committee on Commerce, Science, and Transportation, United States Senate (June 2014)
• Hisamitsu Pharmaceutical, Inc. (Salonpas Pain Relief Patch, Salonpas Arthritis Pain Patch, and Salonpas Gel Patch Hot) – Response to NAD referral (May 2014)
• Xlear, Inc. (Spry Dental Defense System) – Response to NAD referral (February 2014)
• Allen Harim Food LLC (Nature's Selection Poultry) – Response to NAD referral (February 2014)
• Maxam Nutraceuticals (PCA Natural Support for Natural Toxin & Waste Elimination) – Response to NAD referral (November 2013)
• Gillette Company (Venus ProSkin MoistureRich Razor) – Response to NAD referral (May 2013)
• Summit Metal Products, Inc. (Rain Deck) – Response to NAD referral (May 2013)
• Star Herbs (My Low Press) – Reponse to NAD referral (March 2013)
• Letter to CARU re Clearwater Aquarium (seewinter.com) (April 2012)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Dr. Gary Arbuckle and Ms. Amy Freeze, theoriginalncgdrops.com and resetthebody.com (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Kevin Wright, HCG Platinum, LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Clint Ethington, HCG Diet Direct LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Greg Grimshaw, hcg-miracleweightloss.com (November 2011)
• Prepared Statement of the Federal Trade Commission On "Protecting Children's Privacy in an Electronic World" – Before the Subcommittee on Commerce, Manufacturing, and Trade of the Committee on Energy and Commerce, United States House of Representatives (October 2011)
• Hewlett-Packard Co. (HP printer cartridges) (April 2011)
• Prepared Statement of the Federal Trade Commission On Peer-To-Peer File-Sharing Technology Issues – Before the Committee on Oversight and Government Reform, United States House of Representatives (July 2007)